Dextromethorphan for Tardive Dyskinesia

Jungjin Kim

Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA

James Donovan

Private Practice, Syracuse, New York, USA

Thomas L. Schwartz *

Department of Psychiatry, SUNY Upstate Medical University, Syracuse, New York, USA

*Author to whom correspondence should be addressed.


Abstract

Aims: To report three cases of successful treatment of tardive dyskinesia (TD) with dextromethorphan.

Study Design:  Retrospective chart review.

Place and Duration of Study: Private outpatient practice in Syracuse, NY.

Methodology: A retrospective chart review of patients with TD who were treated with dextromethorphan between 2003 and 2013 was conducted.

Results: Three consecutive patients experienced marked improvement of TD with dextromethorphan.

Conclusion: Dextromethorphan may be a useful drug for treating TD. Further prospective studies are needed.

  

Keywords: Tardive dyskinesia, dextromethorphan, dextromethorphan-quinidine


How to Cite

Kim, Jungjin, James Donovan, and Thomas L. Schwartz. 2014. “Dextromethorphan for Tardive Dyskinesia”. International Neuropsychiatric Disease Journal 2 (3):136-40. https://doi.org/10.9734/INDJ/2014/7970.

Downloads

Download data is not yet available.